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Abstract
Purpose: This study aims to translate the Distress Thermometer (DT) into Indonesian, test its validity in Indonesian women
with breast cancer and determine norm scores of the Indonesian DT for clinically relevant distress.
Methods: First, the original version of the DT was translated using a forward and backward translation procedure according
to the guidelines. Next, a group of 120 breast cancer patients who were treated at the Outpatient Surgical Oncology Clinic
in Hasan Sadikin Hospital in Indonesia completed a standard socio-demographic form, the DT and the Problem List, the
Hospital Anxiety and Depression Scale (HADS) and the WHO Quality of Life (WHOQOL-BREF).
Results: Receiver operating characteristic (ROC) curve analyses identified an area under the curve = 0.81 when compared to
the HADS cutoff score of 15. A cutoff score of 5 on the DT had the best sensitivity (0.81) and specificity (0.64). Patients who
scored above this cutoff reported more problems in the practical, family, emotional, spiritual/religious and physical domains
(30 out of 36 problems, p-value,0.05) than patients below the cutoff score. Patients at advanced stages of cancer
experienced more emotional and physical problems. Patient’s distress level was negatively correlated with overall quality of
life, general health and all quality of life domains.
Conclusions: The DT was found to be a valid tool for screening distress in Indonesian breast cancer patients. We
recommend using a cutoff score of 5 in this population.
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Introduction
In Indonesia, cancer incidence has an estimated number about
300,000 cases per year [1]. However, only 10% of these cases are
treated in the health care system as the majority of these people do
not seek medical help due to several factors, such as strong beliefs
in traditional healers, fear and denial, and cultural taboos [2–3].
As one of the ten identifiable main diseases causing death in
Indonesia [4], the diagnosis of cancer and its treatment often
causes considerable psychological distress in patients. It has been
recognized and reported in previous studies that 20–40% of cancer
patients experience a significant level of distress [5–6]. Breast
cancer is the primary cancer in Indonesia and its incidence and
mortality rate is increasing [7]. Previous findings have shown that
women with breast cancer experience psychological distress [8],
even years after disease diagnosis and treatment [9]. Patients’
distress is associated with a number of negative outcomes,
including low adherence to treatment recommendation [10], poor
satisfaction with care [11] and poor quality of life [12].
Similar to developed countries [13–14], distress among cancer
patients often goes unrecognized by health care professionals in
Indonesia. The ratio between the amount of health care
professionals and cancer patients is still far from ideal in Indonesia.
Data from 506 Government Hospitals in Indonesia showed that in
average there are only 14 General Practitioners and 16 Specialists
per hospital [4]. This condition may lead to several practical
issues, including limited consultation time. In addition, a
paternalistic style of doctor-patient communication and patients’
unassertiveness are quite common in Indonesia [15]. These factors
may also cause consultations to be focused primarily on physical
aspects of cancer.
The National Comprehensive Cancer Network (NCCN) states
that distress should be recognized, monitored, documented and
treated promptly at all stages of the disease and in all settings [16].
Considering the high patients load and the unbalanced ratio
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between patients and health care professionals in Indonesia, there
is an urgent need for a short and effective screening tool to detect
distress among patients. Ideally, such a tool should be able to assess
distress across the physical, psychological, social and spiritual
domains [17]. As current screening tools are long and burdensome
for patients to complete, there is a need for a brief, valid and easy
to complete measure of distress in this population.
In order to meet this demand, the NCCN has developed the
Distress Thermometer (DT) which is a single item that asks the
patients to rate their distress using a visual analogue scale. It is
accompanied by the Problem List (PL) that asks patients to identify
any of 36 issues that have been a problem for them in the past
week. The DT is very brief, easy to administer and it uses a word
for psychological problems with non stigmatizing connotations,
namely distress [16]. This tool was initially developed by the
NCCN and many studies have reported that the DT is an effective
screening tool for detecting distress among various medical
conditions, such as prostate carcinoma [18], bone marrow
transplantation [19], lung cancer [20], breast cancer [8] and
mixed site cancer [21]. The NCCN suggests that a score of 4 or
higher on the DT indicates a clinically significant distress level
[16]. Some validation studies using the Hospital Anxiety and
Depression Scale (HADS) found the same cutoff score of 4 [22–
24], whereas other authors found that a cut off score of 5 [25–28]
best distinguished distressed patients from non-distressed ones.
Most studies found that DT scores above the cutoff are correlated
with emotional, family and physical problems as measured by the
Problem List. However, results on spiritual and religious concerns
are inconclusive [21–23].
The Distress Thermometer has been successfully translated
from English into several languages, such as Arabic [29], Dutch
[30], Japanese [25], Korean [23], Turkish [24] and Italian,
Spanish and Portuguese [27], but it has not yet been used in
Indonesian cancer patients. Therefore, this study aims to translate
the DT into Indonesian, test its validity in Indonesian women with
breast cancer by comparing it with a well-established distress
measure, i.e. the HADS, and to determine norm scores of the
Indonesian DT for clinically relevant distress. The other aim was
to establish the validity of the DT by examined its associations with
the Problem List scores, socio-demographic and clinical charac-
teristics, and quality of life.
Methods
Participants
Consecutive sampling was used to recruit 120 women with
breast cancer from the outpatient surgical oncology clinic at Hasan
Sadikin Hospital (HSH) Bandung in two phases. The first group of
50 patients was recruited between April–June 2010; the second
group of 70 patients was recruited between June–October 2011,
due to logistical reasons. Inclusion criteria were age $18 years,
first diagnosis of breast cancer and adequate command of the
Indonesian language. Patients who had been treated by psychi-
atrists were excluded from the study.
Ethics statement
The study was approved by the Indonesian medical ethical
committee and the Board of Directors of Hasan Sadikin Hospital.
All samples were obtained with written informed consent reviewed
by the ethical board.
Procedures
This validation study was part of a larger investigation in which
the correlates of non-adherence behavior in Indonesian breast
cancer patients were explored. After receiving written permission
from the NCCN, we used the forward and back translation
method to translate the DT, since this method is the most
frequently recommended and used method in translation guide-
lines for cross-cultural studies [31]. One of the authors of this study
(A.I) who is a clinical psychologist translated the DT from English
into the Indonesian language; the back translation into English
was carried out by an English language teacher (J.H) who is a
Native American who speaks the Indonesian language fluently and
who has been living in Indonesia for 6 years. Upon completing the
translation, a linguist (A.C) examined the original English version
and the back translation version of the DT to assess the
significance of any discrepancies. After some discussions with
A.C, we finalized the Indonesian version of the Distress
Thermometer.
A member of the administration staff of HSH identified eligible
patients, explained the study purpose to them and asked for their
initial consent to participate. One week later, those who wanted to
participate were approached by one of the research assistants
before their next visit to their physician. Ten master’s students in
clinical psychology were trained as research assistants and were
supervised by S.S (clinical psychologist) and A.I. The research
assistant provided further information about the study and
instructions on how to fill in the questionnaires. After informed
consent had been obtained, participants filled in the DT, the
HADS, the World Health Organization Quality of Life (WHO-
QOL-BREF) and a demographic/background data form. Partic-
ipants filled out the questionnaires in the waiting room before their
consultations. Ten of the participants were illiterate, but they were
able to speak and understand the Indonesian language. In these
cases, the research assistants read both the informed consent form
and the questionnaires out loud. After the participants signed the
informed consent form, the research assistants helped them to fill
in the questionnaires.
Measures
Socio-demographic and medical status. A standard socio-
demographic form was used to collect self-report data on age,
marital status, education level, employment status, insurance status
and family history of breast cancer. The patients’ medical status,
such as type and stage of cancer as defined by the TNM stadium
classification system [32], type of treatment and time since
diagnosis were obtained via a medical chart review.
Distress Thermometer (DT). The DT is a 1-item, self-
report measure of psychological distress developed by the NCCN
[16]. Patients are asked to rate their distress in the past week on an
11-point visual analogue scale ranging from 0 (no distress) to 10
(extreme distress). Afterwards, patients are asked to fill in the
Problem List (PL) that accompanies the visual image of the DT to
check whether or not (yes/no) they experienced any of the
problems listed during the previous 7 days. The PL version used in
this study consisted of 36 problems that were grouped into five
categories, namely practical problems, family problems, emotional
problems, spiritual/religious concerns and physical problems. The
PL aims to better define the nature of the problems which possibly
cause the reported distress. To assess its association with the DT
scores, the total amount of problems checked was calculated
(range 0–36).
Hospital Anxiety and Depression Scale (HADS). The
HADS is a 14-item self-report questionnaire that has been
developed to assess psychological distress in people with medical
illness [33]. It consists of 2 subscales; one subscale consists of 7
items to measure anxiety (HADS-A) and one subscale consists of 7
items to measure depressive symptoms (HADS-D). Respondents
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are asked to indicate which of 4 options (rated 3-0) best describes
their feelings during the previous week, which results in a
maximum score of 21 on each subscale. The sum scores of the
two subscales can be added up to a total score (HADS-T). The
HADS has been widely used to validate the DT because of the
similarity in their conceptual background [18,22–27,30,34–35].
The HADS is available in the Indonesian language, but has not
yet been psychometrically validated in Indonesian patients and
cut-off scores for clinically relevant symptoms are not yet available.
Therefore, in the present study we used the global cutoff score of
the HADS total ($15) that in studies elsewhere distinguished best
between people with and without clinically significant emotional
distress [36–37]. Factor analysis of the Indonesian version of the
HADS demonstrated a two factor solution in good accordance
with the HADS-A and HADS-D subscales, except for item 3: I feel
cheerful and item 4: I feel as if I am slowed down. The solution
accounted for 45% of variance. Both subscales were found to be
internally consistent, with values of Cronbach’s coefficient (alpha)
being 0.77 and 0.74, respectively.
World Health Organization Quality of Life (WHOQOL-
BREF). The WHOQOL-BREF was developed as an abbrevi-
ation of the WHOQOL-100 to provide a short form quality of life
assessment [38] It was developed by the WHO through a
multicentre field trial situated within 23 countries. This tool is a
self-report questionnaire which consists of 26 items, each item
representing one facet of life that is considered to have a
contribution to a person’s quality of life. Twenty-four items
measure four broad domains, namely physical health (e.g.
mobility, pain and discomfort; 7 items), psychological health (e.g.
body image and appearance, negative feelings, self esteem; 6
items), social relationships (e.g. personal relationships, social
support; 3 items) and environment (e.g. financial resources, health
and social care, physical environment; 8 items). Two other items
measure the overall perception of quality of life and general health.
The WHOQOL-BREF employs a 5-points scale (1 to 5) with a
higher score indicating a higher level of self-perceived quality of
life. The WHOQOL-BREF is available in a validated Indonesian
version [39].
Data Analysis
We used the Statistical Package for Social Science (SPSS 17.0)
for data analysis. The mean score, the standard deviation, the
median score and the frequency distribution of the DT were
explored using descriptive statistical analysis. The concurrent and
convergent validity of the DT with the HADS and the
WHOQOL-BREF were examined by Pearson’s correlation
coefficient analyses. Receiver operating characteristic (ROC)
analysis was used to identify the optimal DT cutoff score for
distinguishing whether a patient experiences clinically significant
distress as defined by the HADS. The Area Under the Curve
(AUC) was used to estimate the overall discriminative accuracy of
the DT cutoff score relative to the established cutoff score of the
HADS$15. We used a qualitative guideline for interpreting AUC
values by Hosmer and Lemeshow [40], namely AUC=0.50 as an
indication that the test has no discrimination, AUC#0.70 as an
acceptable discrimination, AUC#0.80 as a good discrimination
and AUC#0.90 as an excellent discrimination. ROC curves were
used to show the trade-off between the sensitivity (true-positive
rate) and specificity (true-negative rate) for every possible cutoff
score of the DT.
To explore the association between the DT cutoff score and the
Problem List, the demographic variables and the clinical variables,
Chi-square analyses were conducted for categorical variables and
t-test analyses were conducted for continuous variables. The
association between the DT and the total score in the PL was
explored by Pearson’s correlation coefficient; associations between
the DT cutoff scores and individual items in the PL were explored
by the Chi-square analyses.
Results
Demographic and clinical characteristics
A total of 120 patients participated in this study. The response
rate was 91%. Twelve out of 132 women approached declined to
participate because they were too ill to fill in the questionnaires. As
shown in Table 1, the mean age of the women in this sample was
approximately 45.5 years of age (range; 28–66). Most of the
participants were married (84%). The majority of the participants
had middle school or lower education (i.e. 49% had elementary
school, 20% had junior high school and 8% had no education).
Seventy-three percent of the participants (73%) were housewives
or unemployed. The mean number of months since diagnosis was
21.5 (SD=20.3, range = 1–120 months). More than half of the
study participants (52%) were in the disease stages III or IV. Fifty-
six percent underwent mastectomy, 83% underwent chemother-
apy and 23% underwent radiotherapy. Ninety-three percent of the
participants had health insurance provided by the government to
poor people (e.g. Jakesmas, ASKES, Gakin and Gakinda) and only
7% financed their own medical expenses. Twenty-five percent of
the participants had a family history of breast cancer.
Average score on the DT and the Problem list
The average score of the patients on the DT was 4.7 (SD=2.6).
The most frequent problems checked in descending order in the
practical domain were insurance/financial (60%), transportation
(48%), housing (32%), work/school (24%) and child care (21%).
The most frequently checked problems in the family problems
category were: dealing with children (14%), the ability to have
children (11%) and dealing with a partner (11%). In the emotional
problems category, the most frequently checked problems were
worry (81%), sadness (80%), fears (54%), depression (41%),
nervousness (41%) and loss of interest in usual activities (33%).
Eleven percent of the patients checked the item about spiritual/
religious concerns. The ten most frequently checked problems in
the physical problems category were pain (71%), fatigue (68%),
nausea (55%), sleep (52%), getting around (51%), tingling in
hands/feet (51%), eating (41%), appearance (36%), memory/
concentration (36%) and skin dry/itchy (36%).
Establishment of a DT cutoff score
The Pearson’s correlation coefficient between the DT scores
and the HADS total was 0.58 (p,0.01); the correlation coefficients
between the DT and the HADS-Anxiety and the HADS-
Depression scales were 0.58 (p,0.01) and 0.48 (p,0.01),
respectively. Using the HADS cutoff score of 15 as the criterion,
sixty-two women (52%) were identified as experiencing clinically
significant distress. The ROC analysis obtained the AUC of 0.81
(SE= 0.04; 95%CI= 0.73–0.88; p,0.001) (Figure 1). This AUC
value indicates an excellent discrimination. Table 2 lists the
Sensitivity, Specificity, Positive predictive values and Negative
predictive value on each the DT cut-off point. A cutoff score of 5
on the DT optimally identified 81% of the HADS cases (sensitivity)
and 64% of the HADS non cases (specificity) with positive and
negative predictive values of 70% and 76%, respectively. Of those
screened positive by the DT, 30% would be false positives and of
those screened negative by the DT 24% would be false negatives.
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Associations between the DT cutoff score and the
Problem List items
The DT scores were statistically significantly correlated with the
Problem List total score (r=0.47, p,0.01). In the practical
problems category (p#0.05), the DT cutoff score was significantly
associated with four problems (i.e. child care, housing, insurance/
financial and work/school), and was not associated with transpor-
tation. The DT cutoff score was significantly associated with each
of the problems in the family problems category (p#0.05). Patients
who scored above the cutoff experienced more problems in
dealing with children, dealing with their partner and the ability to
have children. In the emotional problems category (p#0.05), the
DT cutoff score was significantly associated with five problems (i.e.
depression, nervousness, sadness, worry and loss of interest in
usual activities), and was not associated with fears. Patients who
scored above the cutoff experienced more spiritual/religious
concerns (p#0.05). Finally, in the physical problems category
(p#0.05), the DT cutoff score was significantly associated with 17
out of 21 problems (i.e. appearance, bathing/dressing, breathing,
changes in urination, constipation, diarrhea, eating, fatigue, feeling
swollen, fever, indigestion, memory/concentration, mouth sores,
nose dry/congested, pain, sexual and skin dry/itchy), and was not
associated with four other problems (i.e. getting around, nausea,
sleep and tingling in hand/feet).
Demographic and clinical characteristics associated with
the DT cutoff score and the Problem List items
Marital status and insurance status were excluded in the Chi-
square analyses, as some categories did not fulfill the minimum
number of expected observations. We found that women with a
score below the DT cutoff score of 5 did not differ significantly
from women at or above the DT cutoff score of 5 on age, time
since diagnosis, education, employment status and family history
of cancer. However, we found a significantly difference in stage of
cancer (x2 = 3.90, df = 1, p=0.048). Women with a score $5 were
more likely to be at an advanced stage of cancer.
We found several significant associations between the PL-scores
and the demographic and clinical characteristics. The advanced
cancer patients (stage III or IV) had higher PL-total scores
(t=23.32, p,0.001), more emotional problems (t=23.55,
p,0.001) and more physical problems (t=22.62, p,0.01) than
the stage I or II cancer patients. Age was negatively correlated
with physical problems (r=20.21, p,0.05) and the PL-total scores
(r=20.182, p,0.05). PL scores were not associated with marital
status, employment status, family history of cancer and time since
diagnosis.
The DT and the HADS correlations with the WHOQOL-
BREF scores
Table 3 shows the correlation coefficients of distress and quality
of life. The DT, the HADS total, the HADS Anxiety and the
HADS Depression scores were significantly negatively correlated
with overall quality of life, general health and all quality of life
domains.
Discussion
In this study, we examined the validity of the DT and its
screening efficacy in detecting distress in Indonesian cancer
patients. Our results showed that the Indonesian version of the
DT has concurrent validity with the HADS, which is a well-
established screening tool for distress. A cutoff score of 5 on the
DT yielded optimal sensitivity and specificity. Patients who had a
score above the cutoff score of 5 experienced more problems in the
practical, family, emotional, spiritual/religious and physical
domains than women with DT scores below this cut off score.
Also, they were more likely to be at an advanced stage of cancer.
Finally, distress as measured with the DT was found to be
negatively correlated with overall quality of life, general health and
all quality of life domains which establish the convergent validity of
the Indonesian version of the DT.
The ROC analysis comparing the DT scores with the well-
established HADS cutoff score of 15 obtained an AUC which
indicates a good discrimination. Using the DT cutoff score of 5,
eighty-one percent patients were identified correctly as being
distressed and 64% identified correctly as not being distressed
which is comparable to the result of the meta-analysis study by
Mitchell [41]. This evidence shows that the DT has a screening
efficacy for distress in Indonesian breast cancer patients. The
Table 1. Demographic and clinical characteristics of study
participants.
Variable n (%)
Age (M6SD) 45.568.04
Marital Status
Married 101 (84%)
Single 2 (2%)
Divorced 0 (0%)
Widowed 17 (14%)
Education (highest)
None 10 (8%)
Elementary school 59 (49%)
Junior high school 24 (20%)
Senior high school 21 (18%)
College or university 6 (5%)
Employment
Housewife/unemployed 88 (73%)
Laborer/irregular job 25 (21%)
Private employee 2 (2%)
Government officer 5 (4%)
Months since diagnosis (M6SD) 21.5620.3
Range (months) 1–120
Current stage of cancer
1 3 (3%)
2 54 (45%)
3 46 (38%)
4 17 (14%)
Treatment
Mastectomy 67 (56%)
Chemotherapy 99 (83%)
Radiotherapy 28 (23%)
Health insurance
Yes 112 (93%)
No 8 (7%)
Family history of breast cancer
Yes 30 (25%)
No 90 (75%)
doi:10.1371/journal.pone.0056353.t001
The Distress Thermometer and Its Validity
PLOS ONE | www.plosone.org 4 February 2013 | Volume 8 | Issue 2 | e56353
current Distress Management Guidelines from the NCCN
recommend that a DT score of 4 or higher indicates that a
patient has a clinical significant level of distress and should be
referred to a psychosocial care team [16]. However, we obtained a
sensitivity of 90% and a specificity of 50% at a cutoff score of 4,
resulting in a large proportion of patients incorrectly being
identified as experiencing clinically significant distress. Consider-
ing the lack of health care professionals in Indonesia, we believe
that it is more appropriate to use the cutoff score of 5 which
yielded an optimal combination of sensitivity and specificity, to
avoid a large number of false positive cases being diagnosed.
Patients who may not require further intervention may feel
burdened by further screening procedures. Moreover, false
positive screening leads to higher health care costs and an
increased need for health professionals. The DT cutoff score of 5
found in this study corresponds with the cutoff score found by
other validation studies using the HADS [25–27,34–35]
Figure 1. Receiving operation characteristic (ROC) curve of Distress Thermometer scores versus Hospital Anxiety and Depression
Scale cutoff scores.
doi:10.1371/journal.pone.0056353.g001
Table 2. Sensitivity, Specificity, Positive and Negative predictive values on each the Distress Thermometer cut-off point.
Cut-off point Sensitivity Specificity Positive predictive value Negative predictive value
0/1 0.98 0.11 0.51 0.88
1/2 0.95 0.21 0.56 0.80
2/3 0.92 0.40 0.62 0.82
3/4 0.90 0.50 0.66 0.83
4/5 0.81 0.64 0.70 0.76
5/6 0.52 0.91 0.86 0.64
6/7 0.42 0.95 0.90 0.60
7/8 0.24 0.98 0.94 0.54
8/9 0.15 1.00 1.00 0.52
9/10 0.10 1.00 1.00 0.51
doi:10.1371/journal.pone.0056353.t002
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Patients who had significant distress were more likely to report
more problems in the practical, family, emotional, spiritual/
religious and physical domains. Interestingly, patients who had
clinically significant distress were more likely to experience
spiritual/religious concerns which is similar to the results of a
study conducted in Korea [23]. In contrast, most studies
conducted in Western countries found that clinically significant
distress was not associated with spiritual/religious concerns
[20,22,24], or only weakly related [34]. The significant correlation
between high distress and spiritual/religious concerns is possibly
due to the fact that Indonesian people are religious and have a
strong belief in God. Many people rely on God to heal their
disease. We hypothesize that people who do not feel any change in
their illness will be more convinced their cancer as the will of God
and they cannot change their destiny which in turn might trigger
higher levels of distress.
Results of studies on associations between distress and socio-
demographic and clinical characteristics in cancer patients are
inconsistent [42]. In the present study, high distress was only found
to be associated with stage of cancer, but not with other socio-
demographic or clinical characteristics. This finding is concor-
dance with previous studies that also unable to find significant
associations between the DT and socio-demographic and clinical
characteristics [18–19,23–24,27,43]. Our finding that distress is
associated with lower overall quality of life, general health and all
quality of life domains is in line with the studies by Skarstein et al.
[12] and Ozalp et al. [24], and further proves the validity of the
Indonesian version of the DT.
The Problem List scores were associated with several demo-
graphic and clinical characteristics in the expected direction,
suggesting that the Indonesian version of the Problem List is also a
valid tool. Advanced cancer patients experienced more emotional
problems and physical problems than patients at an early stage of
cancer, and younger patients experienced more physical problems.
These results are in line with previous studies results [44–45].
Several limitations of this study should be noted. Firstly, we used
only breast cancer patients as our sample. Furthermore, we
conducted this study at HSH which is a referral hospital that
provides health services to the poor people. Therefore, the
majority of the study participants had middle to low socio-
economic and educational level. However, demographic and
clinical characteristics of the patients (e.g. mean age, education
level, marital status and stage of cancer) were similar to previous
studies in Indonesian breast cancer patients [46–47]. Multi-center
studies with a larger sample of various patient groups are needed
to be able to extrapolate these results of the present study to other
patient groups. Secondly, all measures used were self-rating
questionnaires. Nevertheless, we included ten illiterate participants
and they were helped to fill out the questionnaires. This may have
led to some bias. Thirdly, the HADS Indonesian version has only
been linguistically validated by the MAPI Institute which may
have lead to some cultural bias. However, the basic psychometric
examination results indicated that the HADS Indonesian version
can be considered as a good instrument in terms of factor structure
and internal consistency. Since the Geriatric Depression Scale,
which is an instrument that is similar to the HADS has been
shown to have the same optimal cut off point in both Western and
Asian countries [48], we used the general HADS cutoff score
suggested for Western countries in our study. Finally, this study
examined the validity of the DT, but further research is required
involving oncologists and nurses to confirm the feasibility of its use
in daily care practice.
Bearing these limitations in mind, our findings suggest that the
Indonesian version of DT could be used as a screening tool in daily
cancer care in Indonesia. As the DT is brief and easy to
administer, it might be an acceptable tool for oncologists in
Indonesia. The NCCN suggests that early detection and treatment
of distress leads to better adherence to treatment, better
communication and prevents severe anxiety and depression [6].
According to our findings, cancer patients who experience distress
above the DT cutoff score of 5 should be referred to a psychologist
or another health professional to manage their distress and get
appropriate treatment of their main distress sources as indicated in
the PL. The use of the DT in daily cancer care in Indonesia may
help oncologists to prevent potential severe psychological problems
in cancer patients and provide additional interventions to patients
who need it. Our results suggest that patients in an advanced stage
of cancer should be given priority for psychological intervention.
Such interventions are often part of medical psychology. Given
that the field of medical psychology is new in Indonesia, we
recommend its development by psychological faculties with
academic hospitals in order to be able to provide adequate
psychological resources to patients and doctors.
Our study did not only confirm the validity of the DT in
Indonesian population, but also showed specific associations with
several problems in the problem list. We found that women with
breast cancer in Indonesia, most of whom are very religious, have
different sources of distress than breast cancer patients in Western
countries. In this respect, our study sheds light on cultural factors
explaining cancer-related distress, thereby generating knowledge
that is not only useful for physicians working in Asian countries,
but also for physicians working with Asian populations in Western
countries.
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Table 3. Association between distress and quality of life.
DT HAD-A HAD-D HADS-T
Overall quality of life 20.36** 20.40** 20.32** 20.39**
General health 20.43** 20.44** 20.31** 20.41**
Physical health domain 20.45** 20.45** 20.53** 20.54**
Psychological domain 20.55** 20.55** 20.53** 20.59**
Social relationships domain 20.22* 20.29** 20.38** 20.35**
Environment domain 20.31** 20.30** 20.36** 20.36**
DT: Distress Thermometer; HAD-A: HAD Anxiety subscale score; HAD-D: HAD
Depression subscale score; HADS-T: Hospital Anxiety and Depression Scale total
score.
*Correlation is significant at the 0.05 level (2-tailed).
**Correlation is significant at the 0.01 level (2-tailed).
doi:10.1371/journal.pone.0056353.t003
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